Cargando…
Engineered exosomes reprogram Gli1(+) cells in vivo to prevent calcification of vascular grafts and autologous pathological vessels
Calcification of autologous pathological vessels and tissue engineering blood vessels (TEBVs) is a thorny problem in clinic. However, there is no effective and noninvasive treatment that is available against the calcification of TEBVs and autologous pathological vessels. Gli1(+) cells are progenitor...
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Association for the Advancement of Science
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10361604/ https://www.ncbi.nlm.nih.gov/pubmed/37478186 http://dx.doi.org/10.1126/sciadv.adf7858 |